ArticleJournal of the National Cancer Center2022

Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.